e-learning
resources
Virtual 2021
07.09.2021
What's new in respiratory problems in rare and systemic diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
The frequency of the respiratory comorbidities in patients (pts) with rheumatoid arthritis (RA)
L. Botvinikova (Dniepropetrovsk, Ukraine), L. Konopkina (Dniepropetrovsk, Ukraine), O. Myronenko (Dniepropetrovsk, Ukraine), O. Plekhanova (Dniepropetrovsk, Ukraine)
Source:
Virtual Congress 2021 – What's new in respiratory problems in rare and systemic diseases
Session:
What's new in respiratory problems in rare and systemic diseases
Session type:
E-poster
Number:
3297
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Botvinikova (Dniepropetrovsk, Ukraine), L. Konopkina (Dniepropetrovsk, Ukraine), O. Myronenko (Dniepropetrovsk, Ukraine), O. Plekhanova (Dniepropetrovsk, Ukraine). The frequency of the respiratory comorbidities in patients (pts) with rheumatoid arthritis (RA). 3297
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Definition and history of sarcoidosis
Evidence of early abnormal airways’ inflammation in children with type 1 diabetes
Related content which might interest you:
Effect of tocilizumab on interstitial lung disease (ILD) in patients with rheumatoid arthritis (RA)
Source: Virtual Congress 2020 – Non-idiopathic pulmonary fibrosis interstitial lung diseases: mechanisms, diagnosis and treatment
Year: 2020
Features and functional deterioration in interstitial lung disease (ILD) asociated to rheumatoid arthritis (RA)
Source: International Congress 2019 – Assessment and management of immune-mediated interstitial lung diseases
Year: 2019
Evaluation of galactomannan (GM) antigen in patients with rheumatoid arthritis (RA)
Source: Annual Congress 2010 - The spectrum of lower respiratory tract infections: risk factors of poor outcome and diagnostic tools
Year: 2010
The lung in rheumatoid arthritis: drugs versus underlying disease
Source: Annual Congress 2009 - Lung disease in rheumatoid arthritis treated with tumour necrosis factor inhibitors: a pulmonary perspective
Year: 2009
Plethysmographic profile of patients with rheumatoid arthritis (RA): a comparative study between ACPA positive and negative patients
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
The diagnostic of the respiratory pathology in patients with rheumatoid arthritis (RA)
Source: International Congress 2016 – The best clinical approach to lung diseases
Year: 2016
Physical activity and quality of life in subjects with chronic diseases; COPD compared to rheumatoid arthritis and diabetes
Source: Annual Congress 2008 - Rehabilitation and influencing factors
Year: 2008
Are smoking and COPD associated with ILD onset in rheumatoid arthritis?
Source: Virtual Congress 2020 – Predictive markers of progression in connective tissue disease-associated interstitial lung disease and hypersensitivity pneumonitis
Year: 2020
Effect of respiratory pathology on the quality of life for patients, suffering from rheumatoid arthritis
Source: Annual Congress 2012 - Respiratory manifestations of systemic disease: a holistic approach
Year: 2012
Impact of systemic inflammation on frequency and severityof mental disorders in COPD patients (pts)
Source: Virtual Congress 2020 – Clinical and functional evaluation of COPD
Year: 2020
Risk factors of interstitial lung diseases in patients with rheumatoid arthritis.
Source: International Congress 2019 – Immune-mediated interstitial lung diseases: from bench to bedside
Year: 2019
Interstitial lung disease (ILD) in patients with polymyositis/dermatomyositis (PM/DM): clinical features and response to treatment in 6 cases
Source: Eur Respir J 2001; 18: Suppl. 33, 528s
Year: 2001
Pulmonary manifestations in patients with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 100s
Year: 2006
Pulmonary involvement in patients with rheumatoid arthritis
Source: Eur Respir J 2006; 28: Suppl. 50, 381s
Year: 2006
Interstitial lung disease in patients with rheumatoid arthritis
Source: Annual Congress 2008 - Sarcoidosis and other interstitial lung diseases
Year: 2008
Infliximab treatment in patients with interstitial lung disease and rheumatoid arthritis
Source: Eur Respir J 2002; 20: Suppl. 38, 587s
Year: 2002
BAL features in patients with systemic scleroris (SSc)
Source: Eur Respir J 2001; 18: Suppl. 33, 410s
Year: 2001
RA autoantibodies as predictors of rheumatoid arthritis in non-cystic fibrosis bronchiectasis patients
Source: Eur Respir J 2014; 44: 1082-1085
Year: 2014
Influence of bacterial colonization (BC) on the level of systemic inflammatory markers (SIM) in COPD patients (pts)
Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities
Year: 2010
Rituximab improves interstitial lung disease in rheumatoid arthritis patients
Source: International Congress 2017 – The spectrum of CTDs: from pathogenesis to treatment
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept